Bupropion Sustained released versus Placebo for seasonal affective Disorder
<p><strong>Background</strong>: The majority of seasonal affective disorder (SAD) studies have evaluated the use of light or selective serotonin reuptake inhibitors (SSRI). The purpose of the present study was to evaluate bupropion sustained-released (SR), a non-SSRI antidepre...
Saved in:
Main Authors: | Martin H Teicher (Author), Danielle M Webster (Author), Steven B Lowen (Author) |
---|---|
Format: | Book |
Published: |
Archives of Depression and Anxiety - Peertechz Publications,
2017-05-26.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Caixàs A, et al.
Published: (2014) -
Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
by: Buehler AM
Published: (2015) -
Bupropion v. Methylphenidate in ADHD
by: J Gordon Millichap
Published: (1995) -
Is There a Potential of Misuse for Venlafaxine and Bupropion?
by: Fabrizio Schifano, et al.
Published: (2018) -
Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT
by: Hajar Pasha, et al.
Published: (2020)